Aethlon Medical, Inc.
AEMD · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $4 | $35 | $62 | $172 |
| - Cash | $6 | $5 | $15 | $17 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | -$0 | $30 | $49 | $156 |
| Revenue | $0 | $0 | $1 | $0 |
| % Growth | – | -100% | 95.2% | – |
| Gross Profit | $0 | $0 | $1 | $0 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$13 | -$12 | -$12 | -$10 |
| % Margin | – | – | -2,030.1% | -3,500.5% |
| Net Income | -$13 | -$12 | -$12 | -$10 |
| % Margin | – | – | -2,094.9% | -3,540.9% |
| EPS Diluted | -85.8 | -48.6 | -58.6 | -70.6 |
| % Growth | -76.5% | 17.1% | 17% | – |
| Operating Cash Flow | -$8 | -$10 | -$11 | -$10 |
| Capital Expenditures | $0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$8 | -$10 | -$11 | -$10 |